These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7026979)

  • 61. Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women.
    Jespersen CM; Arnung K; Hagen C; Hilden T; Nielsen F; Nielsen MD; Giese J
    J Hypertens; 1983 Dec; 1(4):361-4. PubMed ID: 6442719
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of estrogens and progestogens on the endometrium. Modern approach to treatment.
    Whitehead MI; Fraser D
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):299-320. PubMed ID: 3306523
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
    Jensen GF; Meinecke B; Boesen J; Transbøl I
    Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
    Jensen J; Nilas L; Christiansen C
    Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psychophysiological stress responses in postmenopausal women before and after hormonal replacement therapy.
    Collins A; Hanson U; Eneroth P; Hagenfeldt K; Lundberg U; Frankenhaeuser M
    Hum Neurobiol; 1982; 1(2):153-9. PubMed ID: 7185790
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
    Mattsson LA; Cullberg G; Samsioe G
    Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
    Bone; 1989; 10(5):313-20. PubMed ID: 2690898
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy.
    Mattsson LÅ; Ipsen HE; Granqvist CJ; Kokot-Kierepa M;
    Climacteric; 2015 Jun; 18(3):419-25. PubMed ID: 25603163
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders.
    Saarikoski S; Yliskoski M; Penttilä I
    Maturitas; 1990 Jun; 12(2):89-97. PubMed ID: 2255266
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
    Williams SR; Frenchek B; Speroff T; Speroff L
    Am J Obstet Gynecol; 1990 Feb; 162(2):438-46. PubMed ID: 2309827
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
    Hellberg D; Nilsson S
    Maturitas; 1987 Apr; 9(1):103-7. PubMed ID: 2955203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
    Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
    Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
    Strandberg TE; Ylikorkala O; Tikkanen MJ
    Am J Cardiol; 2003 Jul; 92(2):212-4. PubMed ID: 12860228
    [No Abstract]   [Full Text] [Related]  

  • 76. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
    Sturdee DW; Archer DF; Rakov V; Lang E;
    Climacteric; 2008 Feb; 11(1):63-73. PubMed ID: 18202966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Jensen J; Riis BJ; Strøm V; Christiansen C
    Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW; Gluck OS; Lang E; Rakov V
    Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy.
    Okon MA; Lee S; Laird SM; Li TC
    Hum Reprod; 1998 Aug; 13(8):2261-5. PubMed ID: 9756307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review.
    Riis BJ; Lehmann HJ; Christiansen C
    Am J Obstet Gynecol; 2002 Oct; 187(4):1101-16. PubMed ID: 12389012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.